News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
Partners

Katy Beckermann, MD, PhD

Articles by Katy Beckermann, MD, PhD

Dose Reductions Possible for Tivozanib With and Without Nivolumab for RCC

ByKaty Beckermann, MD, PhD

February 20th 2025

Katy Beckermann, MD, PhD, explained that oncology nurses and APPs should be ready to administer and explain dose modifications for patients with RCC.

Latest Updated Articles

Trending on Oncology Nursing News

PROs Show Less Emotional Function for Younger Female Patients With Cancer

Open-Label Ponsegromab Appears Effective in Cancer-Associated Cachexia

Niraparib/Abiraterone Acetate Combo Maintains Baseline HR-QOL in HRRM+ mHSPC

© 2025 MJH Life Sciences^®

All rights reserved.